Literature DB >> 10957907

Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section D: chronic critical limb ischaemia.

.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10957907

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN： 1078-5884            Impact factor:   7.069


× No keyword cloud information.
  10 in total

1.  Real-time magnetic resonance imaging-guided endovascular recanalization of chronic total arterial occlusion in a swine model.

Authors:  Amish N Raval; Parag V Karmarkar; Michael A Guttman; Cengizhan Ozturk; Smita Sampath; Ranil DeSilva; Ronnier J Aviles; Minnan Xu; Victor J Wright; William H Schenke; Ozgur Kocaturk; Alexander J Dick; Venkatesh K Raman; Ergin Atalar; Elliot R McVeigh; Robert J Lederman
Journal:  Circulation       Date:  2006-02-20       Impact factor: 29.690

2.  Lifelong limb preservation: A patient-centered description of lower extremity arterial reconstruction outcomes.

Authors:  Katie E Shean; Peter A Soden; Marc L Schermerhorn; Sara L Zettervall; Sarah E Deery; Jeremy D Darling; Allen Hamdan; Frank W LoGerfo
Journal:  J Vasc Surg       Date:  2017-05-11       Impact factor: 4.268

3.  7(th) Asian PAD Workshop.

Authors: 
Journal:  Ann Vasc Dis       Date:  2016-05-25

4.  The contralateral extremity has also benefit from the locally administered bone marrow-derived mononuclear cells and cord blood serum in diabetic ischemic wound healing.

Authors:  A Tulga Ulus; Ferda Alpaslan Pınarli; Devrim Sonmez; Ahmet Yesilyurt; Tuncay Delibasi
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

Review 5.  Spinal cord stimulation for patients with inoperable chronic critical leg ischemia.

Authors:  Xiao-Pei Chen; Wei-Min Fu; Wei Gu
Journal:  World J Emerg Med       Date:  2011

6.  Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans.

Authors:  Shinobu Sugihara; Yasutaka Yamamoto; Koichi Matsubara; Katsunori Ishida; Takashi Matsuura; Fumihiro Ando; Go Igawa; Genta Narazaki; Junichiro Miake; Fumihito Tajima; Ryutaro Nishio; Bin Nakayama; Osamu Igawa; Chiaki Shigemasa; Ichiro Hisatome
Journal:  Heart Vessels       Date:  2006-07       Impact factor: 1.814

7.  Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial.

Authors:  Marlon I Spreen; Jasper M Martens; Bettina E Hansen; Bob Knippenberg; Elke Verhey; Lukas C van Dijk; Jean-Paul P M de Vries; Jan-Albert Vos; Gert Jan de Borst; Evert-Jan P A Vonken; Jan J Wever; Randolph G Statius van Eps; Willem P Th M Mali; Hans van Overhagen
Journal:  Circ Cardiovasc Interv       Date:  2016-02       Impact factor: 6.546

8.  Role of plasma growth factor in the healing of chronic ulcers of the lower legs and foot due to ischaemia in diabetic patients.

Authors:  Tomasz Miłek; Krzysztof Baranowski; Piotr Zydlewski; Piotr Ciostek; Krzysztof Mlosek; Wojciech Olszewski
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

9.  Primary stenting for femoropopliteal peripheral arterial disease: analysis up to 24 months.

Authors:  Martin Andreas Geiger; Ana Terezinha Guillaumon
Journal:  J Vasc Bras       Date:  2019-01-30

Review 10.  Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia.

Authors:  Frantisek Jaluvka; Peter Ihnat; Juraj Madaric; Adela Vrtkova; Jaroslav Janosek; Vaclav Prochazka
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.